Business
OTC Markets Group Welcomes New OTCQB Companies – July 11
OTC Markets Group Welcomes New OTCQB Companies – July 11.
About this update from Lexington Biosciences Inc
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following companies are approved for trading on the OTCQB® Venture Market:First Harvest Corp. (OTCQB: HVST) First Harvest is a platform for tech, media and gaming with a focus on the cannabis industry and emerging growth sectors. This ecosystem spans mobile gaming, digital and social media, e-commerce sales and education. First Harvest's platform connects mainstream advertisers to pro-legalization supporters of medical and therapeutic cannabis. The Company uses gaming and digital media as a sales platform with a unique marketing strategy that leverages viral and social mechanisms. The Company's two business platforms include: (1) mobile gaming, Hemp Inc., and (2) social media, Cannavoices. First Harvest believes its platforms are educational, insightful and entertaining.Lexington Biosciences Inc. (CSE: LNB; OTCQB: LXGTF) Lexington Biosciences is a medical device company that is developing the HeartSentry, a new non-invasive diagnostic device to measure and monitor cardiovascular health by assessing the function of a person’s vascular endothelium — the vital innermost lining of a person’s cardiovascular system. Traditionally, this has only been measured using ultrasound and other complex, difficult to use technologies. The HeartSentry technology core research was created at the University of California Berkeley over a fifteen-year period involving many studies and product iterations resulting in a portfolio of multiple pending and issued patents licensed to the company. The company is in the final stages of releasing the developed product for clinical studies. The aim is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health. Lexington is engaged with the US FDA and other regulatory agencies on the required product approvals for the HeartSentry.U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com.About OTC Markets Group Inc.OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global ...